GI & Endoscopy

Colorectal cancer therapy market to hold steady at $7.7B

The market for colorectal cancer therapies will hold steady, valued at $7.7 billion by 2023, according to a Decision Resources Group news release.

Carrie Pallardy

Tuesday, September 2nd, 2014

The report covers the United States, France, Germany, Italy, Spain, Japan and the United Kingdom.

More articles on gastroenterology:
A world without colonoscopy? 9 gastroenterologists weigh in on the future of GI’s top procedure
Are surveillance colonoscopy practices due for an update?
5 things to know about colonoscopy payment: AGA bundle vs. Medicare model

Next Up in GI & Endoscopy

ConMed to end its GI product lines

Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines. ConMed’s gastroenterology segment is projected…

By: Cameron Cortigiano
Yesterday
Gastroenterologists find success in using AI for surveillance colonoscopy intervals

Gastroenterologists at the University of Miami Miller School of Medicine and the University of Pennsylvania Perelman School of Medicine have…

By: Cameron Cortigiano
2 days ago
The titans of gastroenterology M&A

Here are three major GI groups leading gastroenterology practice acquisitions and ASC growth: GI Alliance Southlake, Texas-based GI Alliance is…

By: Patsy Newitt
2 days ago

Comments are closed.